E-DRUG: ARV protocols and needs
-------------------------------
I am working to try to understand the importance of ARV protocols in the
field.� I know that most countries have adopted a regimen of two NRTIs
plus an NNRTI as first line, and often have a PI (usually
ritonavir-boosted) as second line.� If PIs were to become more easily
available (e.g. cheaper), would they be used interchangeably with NNRTI's
in the field, or would physicians likely stick to protocols?� Or would it
depend on the PI (e.g. high pill burden/ side effects probably not, low
side effects and few pills probably; ritonavir-boosted probably not,
non-boosted yes)?
Michelle Forrest
[please specifiy affiliation next time - thanks, WB]
mforrest28@hotmail.com
[Very specific ARV related questions are probably better placed in the e-3x5
discussion group.
http://list.healthnet.org/mailman/listinfo/e-3x5
To join, send blank message to e-3x5-join@healthnet.org
WB]
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug